• |
  • viernes 30 de julio de 2021

Nuevo Índice de Impacto de Clinical and Translational Oncology

Recientemente hemos conocido el nuevo IF de Clinical and Translational Oncology, pasando de 2.737 en 2019 a 3.405 en 2020. Enhorabuena para todos los que han contribuido a ello.
 

The Federation of Spanish Oncology Societies (FESEO) is a national stage federation, non-profit, and it is made up of the five Spanish oncology societies (ASEICA, SEHOP, SEOM, SEOQ and SEOR) and its objective is to promote interdisciplinarity among its societies as well as with entities outside the Federation. FESEO publishes the journal Clinical & Translational Oncology, the Federation's organ of expression and to which all members of each of the societies that make up FESEO have free access. It is published entirely in English and has a monthly periodicity (12 issues per year); occasionally extraordinary issues are published dedicated to monographs of special interest to the oncological community and to numbers of congresses of the societies that integrate it. Clinical & Translational Oncology is being edited by Springer which guarantees the application of rigorous evaluation standards. This editing agreement allows works to be indexed from the moment they are published online, which helps to increase the Impact Index year after year.

About FESEO

The Federation of Spanish Oncology Societies (FESEO), formed by the Spanish oncology societies (ASEICA, SEHOP, SEOM, SEOQ and SEOR), publishes the journal Clinical and Translational Oncology.

Our Contacts

C/ Infanta Isabel, 29, 1º Izda.
28014 Madrid (Spain)

(+34) 640509590

moc.oesef@otc